HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kei Ohnuma Selected Research

ErbB Receptors (EGF Receptor)

1/2021IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kei Ohnuma Research Topics

Disease

26Neoplasms (Cancer)
03/2021 - 05/2002
10Malignant Mesothelioma
01/2019 - 07/2007
4Immune System Diseases (Immune Disorders)
01/2019 - 03/2007
3Bronchiolitis Obliterans Syndrome
12/2022 - 04/2015
2Leukemia
12/2022 - 02/2007
2Carcinogenesis
02/2021 - 03/2007
2Psoriasis (Pustulosis Palmaris et Plantaris)
11/2019 - 01/2019
2Neoplasm Metastasis (Metastasis)
01/2019 - 03/2007
2Inflammation (Inflammations)
01/2018 - 04/2011
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2016 - 05/2002
2Bronchiolitis
01/2016 - 04/2015
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2013 - 08/2005
2Type 2 Diabetes Mellitus (MODY)
10/2013 - 10/2010
2Graft vs Host Disease (Graft-Versus-Host Disease)
07/2013 - 02/2004
2Carcinoma (Carcinomatosis)
02/2011 - 06/2006
2Hypoxia (Hypoxemia)
06/2005 - 12/2003
1Lung Injury
03/2024
1Pulmonary Hypertension
01/2024
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2024
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2023
1Weight Loss (Weight Reduction)
12/2022
1Diabetes Mellitus
02/2021
1Triple Negative Breast Neoplasms
01/2021
1Rheumatic Diseases (Rheumatism)
09/2019
1Erythema
01/2019
1Atherosclerosis
01/2018
1Pruritus (Itching)
06/2017
1Hypersensitivity (Allergy)
04/2017
1Edema (Dropsy)
02/2016
1Synovitis
02/2016
1Experimental Arthritis
07/2015
1Arthritis (Polyarthritis)
05/2015
1Fibrosis (Cirrhosis)
04/2015
1Insulin Resistance
03/2015
1Pleural Diseases
01/2014
1Infections
12/2013
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
07/2013
1Necrosis
02/2013

Drug/Important Bio-Agent (IBA)

16Monoclonal AntibodiesIBA
12/2022 - 06/2006
10Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
02/2021 - 03/2005
5Dipeptidyl-Peptidase IV InhibitorsIBA
02/2021 - 10/2010
5Proteins (Proteins, Gene)FDA Link
02/2014 - 06/2005
4Membrane Glycoproteins (Membrane Glycoprotein)IBA
02/2021 - 06/2006
3Glycoproteins (Glycoprotein)IBA
01/2019 - 03/2005
3EnzymesIBA
06/2017 - 06/2009
3CollagenIBA
01/2016 - 02/2014
3Small Interfering RNA (siRNA)IBA
07/2007 - 08/2005
2LipopolysaccharidesIBA
03/2024 - 01/2018
2Sitagliptin Phosphate (Januvia)FDA Link
03/2024 - 04/2011
2indium-bleomycinIBA
01/2024 - 01/2023
2Therapeutic UsesIBA
12/2022 - 11/2019
2Biomarkers (Surrogate Marker)IBA
03/2021 - 01/2014
2Imiquimod (Aldara)FDA LinkGeneric
11/2019 - 01/2019
2Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
01/2018 - 06/2009
2LipidsIBA
01/2016 - 02/2004
2Integrin beta1IBA
03/2007 - 08/2005
2p38 Mitogen-Activated Protein KinasesIBA
03/2007 - 08/2005
2AntigensIBA
01/2006 - 08/2005
1CytokinesIBA
03/2024
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2023
1Hypoglycemic Agents (Hypoglycemics)IBA
02/2021
1Glucose (Dextrose)FDA LinkGeneric
02/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
1Immune Checkpoint InhibitorsIBA
09/2019
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2019
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2019
1Ubiquitin-Specific ProteasesIBA
10/2018
13- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA
01/2018
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2018
1Neurotransmitter Agents (Neurotransmitter)IBA
06/2017
1Substance PIBA
06/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2016
1RoxithromycinIBA
07/2015
1AdipokinesIBA
03/2015
1PeriostinIBA
05/2014
1Caveolin 1IBA
02/2014
1Adenosine DeaminaseIBA
02/2014
1Fibronectins (Fibronectin)IBA
02/2014
1Formaldehyde (Formol)FDA Link
02/2014
1ParaffinIBA
02/2014
1AsbestosIBA
01/2014
1IntegrinsIBA
01/2014
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
11/2013
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2013
1Versicans (Versican)IBA
11/2013
1InterferonsIBA
02/2013
1Granzymes (Granzyme)IBA
02/2013
1Fas Ligand Protein (Fas Ligand)IBA
02/2013

Therapy/Procedure

16Therapeutics
12/2022 - 02/2007
3Transplantation
02/2016 - 05/2002
2Immunotherapy
09/2019 - 10/2010
2Drug Therapy (Chemotherapy)
03/2012 - 03/2007
1Immunomodulation
02/2021
1Premedication
04/2017
1Cell Transplantation
01/2016
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
05/2015
1Hematopoietic Stem Cell Transplantation
04/2015
1Intraperitoneal Injections
07/2013